As noted in our article, regulation of data has emerged as a key focus for Australian regulators in recent years. Consistent with this, on 3 November 2023, the Australian Information Commissioner (AIC) commenced Federal Court proceedings against Australian Clinical Labs (ACL) in respect of a data breach which occurred in February 2022, alleging that it had ‘seriously interfere[ed] with the privacy of millions of Australians’.
In particular, the AIC alleges that ACL has contravened its obligations in the Privacy Act 1988 (Cth) (Privacy Act) to:
In late 2022, the maximum civil penalty applicable to body corporates for serious or repeated breaches of privacy under the Privacy Act was increased (see our article here) to an amount not more than the greater of:
Given that ACL’s alleged conduct occurred prior to these increased penalty provisions, they will not be applicable to ACL should the Federal Court determine ACL contravened the Privacy Act as alleged by the AIC. However, the increased penalties will apply to any organisation who is found to have contravened section 13G of the Privacy Act in relation to conduct occurring on or after December 2022.
APP entities should also be aware that the Australian Government’s response (Response) to the Attorney General’s report which proposed a series of reforms to the Privacy Act (see our article here) agreed with the proposals to strengthen privacy enforcement, including:
Given the Office of the AIC was granted additional funding for enforcement in the 2023-24 budget (see our article here), we expect further regulatory action in this space.